Palmetto Analysis of CMS Data Raises Alarm on Potential Genetic Testing Fraud Premium High payment rates for tests for rare disorders in regions covered by two Medicare Administrative Contractors could spark debate about genetic testing fraud. Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer The Guardant Reveal assay will now be covered for this group of patients as long as testing is initiated within three months after surgery. Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma The firm's assay is the first and only test to gain coverage for this patient population, for whom ctDNA MRD assessment can help personalize treatment. Local Coverage Determinations Roundup: Castle Bio, SkylineDx Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx. Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Tests like MDxHealth's SelectMDx, Bio-Techne's ExoDx Prostate, and various PSA scoring algorithms would be reimbursed if they pass a technical assessment. Apr 19, 2022 Four Years Into Foundational LCDs, Broader Reimbursement Coverage a Mixed Bag, Stakeholders Say Premium Mar 8, 2022 Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test Nov 11, 2021 Palmetto Finalizes Medicare Coverage for MRD Cancer Testing Jun 23, 2021 Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage Jun 4, 2021 Veracyte Bladder Cancer Test Receives Medicare Coverage May 21, 2021 Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Apr 22, 2021 Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 28, 2020 Strata Oncology Receives Medicare Coverage for NGS Test Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 25, 2020 Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test Sep 25, 2020 Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD Sep 10, 2020 Two Medicare Contractors Align Coverage for MRD Testing With Palmetto Sep 3, 2020 Natera Receives LCD From Palmetto for Signatera MRD Test in Colorectal Cancer Patients Jul 28, 2020 NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.